Wound ulcers are painful and costly complications of care. They extend length of stay and dramatically increase costs associated with patient encounters. Negative-Pressure Wound Therapy (NPWT) is a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wound that was cleared for use by the Food and Drug Administration (FDA) back in1995 and subsequently approved for reimbursement by the CMS back in 2001. NPWT can improve healing, reduce lengths of stay and associated costs of care for wound ulcer.
Methodology: PurpleLab examined all HCPs and HCOs for longitudinal experiences with two clinical groupers: (i) wound ulcer diagnosis, and (ii) NPWT procedures. It identified high diagnosing HCPs and HCOs of wound ulcers that are low providers of NPWT treatments. These HCP and HCO providers are the next best sales and marketing opportunities for companies that provide NPWT products and services. Moreover, these HCPs and HCOs are also identifiable to those payers who bear the higher costs associated with the lack of NPWT therapy.